Jure Kapetan

Jure Kapetan has a diverse work experience spanning over several companies and roles. Jure currently serves as the CEO of MERKUR since April 2022. Prior to that, they worked as an Executive at Evok from January 2022 to April 2022. From April 2020 to December 2021, Jure was the Co-CEO at Engrotus d.o.o. Before that, they held the position of Managing Director D/A/CH at Eurofins Biopharma Product Testing from January 2017 to March 2020. Jure also served as the Managing Director at Eurofins BioPharma Product Testing Munich GmbH from August 2015 to March 2020. From April 2010 to July 2015, they worked as the Managing Director at TAD Pharma. Prior to that role, Jure was the Deputy Managing Director at TAD Pharma GmbH, a member of Krka Group, from January 2008 to March 2010. Jure also served as the Deputy Director of Finance at Krka, d.d., Novo mesto, from August 2007 to December 2007. Jure started their professional journey as a student at INSEAD in 2006. Before that, they worked as an Assistant Director of Finance at Krka, d.d., Novo mesto, from August 2005 to July 2006.

Jure Kapetan completed an MBA degree at INSEAD in the year 2007. Prior to that, they obtained a BSc degree in Economics from the University of Ljubljana, which they attended from 1998 to 2002.